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Abstract
Background:  Duffy blood group polymorphisms are important in areas where Plasmodium vivax
predominates, because this molecule acts as a receptor for this protozoan. In the present study, Duffy
blood group genotyping in P. vivax malaria patients from four different Brazilian endemic areas is reported,
exploring significant associations between blood group variants and susceptibility or resistance to malaria.
Methods: The P. vivax identification was determined by non-genotypic and genotypic screening tests. The
Duffy blood group was genotyped by PCR/RFLP in 330 blood donors and 312 malaria patients from four
Brazilian Amazon areas. In order to assess the variables significance and to obtain independence among
the proportions, the Fisher's exact test was used.
Results: The data show a high frequency of the FYA/FYB genotype, followed by FYB/FYB, FYA/FYA, FYA/FYB-
33 and FYB/FYB-33. Low frequencies were detected for the FYA/FYX, FYB/FYX, FYX/FYX and FYB-33/FYB-33
genotypes. Negative Duffy genotype (FYB-33/FYB-33) was found in both groups: individuals infected and
non-infected (blood donors). No individual carried the FYX/FYB-33 genotype. Some of the Duffy genotypes
frequencies showed significant differences between donors and malaria patients.
Conclusion:  The obtained data suggest that individuals with the FYA/FYB  genotype have higher
susceptibility to malaria. The presence of the FYB-33 allele may be a selective advantage in the population,
reducing the rate of infection by P. vivax in this region. Additional efforts may contribute to better elucidate
the physiopathologic differences in this parasite/host relationship in regions endemic for P. vivax malaria,
in particular the Brazilian Amazon region.
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Background
Plasmodium vivax has been the most common cause of the
human malaria parasite in the Brazilian Amazon region
over the last seven years [1]. Innate resistance to malaria
infections in humans is conferred by different blood
group polymorphisms. The association of the Duffy
blood group (FY) with P. vivax human malaria has been
well-documented, where Duffy-negative individuals are
naturally resistant to invasion by this parasite [2].
The Duffy blood group antigen has been identified as a
scavenger on the red blood cell (RBC) surface eliminating
excesses of circulating toxic chemokines, named Duffy
antigen/receptor for chemokines (DARC) [3]. The deter-
minant, a glycoprotein that passes through the membrane
seven times, includes a 35–43 KDa epitope in the extracel-
lular, N-terminal domain that mediates erythrocyte inva-
sion by P. vivax merozoites [4]. The Fy gene has two exons
(Fya and Fyb) that are encoded by the co-dominant alleles
FYA and FYB, located on chromosome 1 [5,6]. The corre-
sponding anti-Fya and anti-Fyb antibodies define four dif-
ferent phenotypes; Fy(a+b+), Fy(a+b-), Fy(a-b+) and Fy(a-
b-) [7]. The FYA and FYB alleles differ by a point mutation
in the major cDNA transcript [8], encoding glycine in Fya
or aspartic acid in Fyb at residue 42 of the most important
form of the protein, encoded by the exon 2 [9,8]. The
molecular mechanism that gives rise to the null Duffy
phenotype [Fy(a-b-)] has been classically associated with
a point mutation in the GATA box of the DARC promoter
which silences the gene encoding the Duffy system anti-
gens in the RBCs of these individuals resulting in a FYB
allele [9]. Recently, the FYA allele has been identified [10]
and a new FYB allele was found with three single nucle-
otide polymorphisms (11). It has been demonstrated in
blood donors from Southeast Brazil that Caucasians and
African descendents were serologically Fy(b-) with the
majority of the African descendents being FYB with the
GATA single nucleotide polymorphism (SNP), while the
majority of Caucasian typing Fy(b-) had FYB with 265T/
298A SNPs [11]. The Fy-negative is common on RBCs of
Negro individuals from ethnic African groups, but it is
rare in many other populations [12].
Previous studies have demonstrated that heterozygous
Duffy negative malaria individuals remain susceptible to
infections by P. vivax [13,14]. It was demonstrated in indi-
viduals living in a malaria endemic region of Papua New
Guinea that Duffy binding protein adherence to RBCs is
significantly reduced for erythrocytes of P. vivax malaria
patients who carry one Duffy-negative allele [15]. In addi-
tion, it was observed that in different areas from the Bra-
zilian Amazon region some of the Duffy phenotypes
showed significant correlation between blood donors and
malaria patients [16]. On the other hand, a previous study
in the Western Brazilian Amazon region (Rondônia State)
did not correlate Fy heterozygosity with protection against
P. vivax [17]. The present study reports the Duffy blood
group genotyping in P. vivax malaria patients from four
different Brazilian endemic areas, exploring these signifi-
cant phenotypic associations between blood group vari-
ants, as well as polymorphic regions of RBC receptors,
with susceptibility or resistance to malaria.
Methods
Study population
The study took place from May 2003 to August 2005. The
vivax malaria patients (n = 312) who were enrolled in this
study complied with the following criteria: they sought
medical assistance presenting clinical malaria symptoms,
were over 18 years old and had positive results for thick
blood film/molecular diagnosis. A control group con-
sisted of blood donors (n = 330) and according to the Bra-
zilian blood bank policy they complied with the
following criteria: they were over 18 years old, of both
genders and belonging to all blood groups. Additionally,
their place of birth was in the study area, they reported
never suffering from malaria attacks and had no signs of
malaria during the initial interview and had negative
results for thick blood film/molecular diagnosis. The con-
trols were matched to the patients in respect to age (± 5
years), gender and ethnicity. All of the control subjects
were genetically independent. Blood samples were col-
lected from all participants (Macapá/Amapá State, Belém/
Pará State, Porto Velho/Rondônia State and Rio Branco/
Acre State), after informed consent.
Genomic DNA extraction, PCR amplification and RFLP 
analysis
The Duffy blood group genotypes were assessed using
PCR/RFLP with modifications as described previously
[11]. Briefly, the DNA was extracted from frozen pellets of
infected erythrocytes using the Easy-DNA™ extraction kit
(Invitrogen, California – USA). The PCR was performed
with 100 ng of DNA, 50 pmol of each primer, 2 nmol each
dNTP, 1.0 U Taq DNA polymerase, and buffer, in a total
volume of 50 µL. The promoter region was amplified
using the FYN1 and FYN2 primers that flank the GATA
box motif. To determine the Duffy RBC polymorphism,
FYAB1 sense, and FYAB2 reverse sense primers were used
[18]. The amplification conditions were performed as
described by Castilho et al [11]. PCR products were run on
1.5% agarose gel, followed by ethidium bromide staining
and photo-documentation using a Gel Doc 1000 (BioRad,
Town, USA). The RFPL analysis was digested during three
hours with Ban1, MspA1 and Sty1 restriction enzymes as
previously described [11].
Statistical analysis
In order to access the significance of the variables and to
obtain independence among the proportions, the Fisher'sMalaria Journal 2007, 6:167 http://www.malariajournal.com/content/6/1/167
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exact test was used. The mean ages of patients and con-
trols were 29 years (± 14 SD) and 28 years (± 8 SD),
respectively. All the studied groups showed no statistically
significant differences in mean ages or ethnicity, indicat-
ing well-matched populations. The same results were
obtained when we compared the two different groups
from each area.
Results
The genotypic and allelic frequencies of the Duffy blood
group in the 330 blood donors and 312 patients infected
by P. vivax as determined by PCR/RFLP are summarized in
Table 1. The data show a high frequency of the FYA/FYB
genotype in 199 individuals (31.0%) of the studied pop-
ulation. This is followed by 117 (18.2%) and 94 (14.6%)
of homozygotes for the FYB and FYA alleles, respectively.
While the frequencies for heterozygote individuals with
FYA/FYB-33 and FYB/FYB-33 were comparable at 14.9%
(96). Low frequencies were detected for the FYA/FYX, FYB/
FYX, FYX/FYX and FYB-33/FYB-33 genotypes. The negative
Duffy genotype (FYB-33/FYB-33) was found in both indi-
viduals infected by P. vivax and unaffected blood donors.
Table 2 shows a comparison of the results of genotyping
and inferred phenotypes of FY among blood donors and
patients infected by P. vivax in the Amazon region. In
respect to the allelic combinations of FY, there was a sig-
nificant difference between donors and patients only for
the FYB-33/FYB-3 genotype (P = 0.0003). As for the heter-
ozygotes, the results demonstrated a significant difference
(P = 0.0404) between those with the FYA/FYB genotype,
which was lower for blood donors (90 - 27.27%) than for
patients infected by P. vivax (109 - 34.93%). No individu-
als were identified with the FYX/FYB-33 genotype.
The frequency of individuals with the FYB-33  allele
among blood donors was 35.15% versus 24.36% in
patients. This difference was statistically significant (P =
0.0033). The prevalence of the FYB allele was significantly
higher (P = 0.0358) among malaria-infected patients.
However, significant differences were not detected in
respect to the frequency of individuals with the FYX and
FYA alleles in the two study groups (Table 2).
Discussion
Thus far, innate resistance to malaria infections in
humans has been attributed to blood group polymor-
phisms. Duffy blood group polymorphisms are important
in areas where P. vivax predominates, because this mole-
cule acts as a receptor for this protozoan (but not for the
other human malaria parasites) on the surface of RBCs
[19]. Field observations from West Africa and Ethiopia
have indeed established a strong correlation between
absence or low endemicity of P. vivax malaria and the high
prevalence of the Duffy negative allele [20,21]. Little is
known on the frequency of RBC polymorphisms that con-
fer either partial or complete resistance against malaria.
The data obtained in the present study emphasize the
importance of the evaluation of Duffy blood group geno-
types in malaria endemic areas of the Brazilian Amazon
region.
The Brazilian population has a highly heterogeneous eth-
nic composition, a result of the hybridization of the
numerous native indigenous populations and immigrants
from Europe, Africa and Asia. The immigration flow was
not uniform in the different regions of the country [22-
24]. The differential distribution of Duffy antigenic deter-
minants among ethnic groups is an aspect characteristic of
this blood system. Hence, this has been used as a marker
Table 1: Genotyping results of the Duffy Blood Group System in 642 individuals (donors and patients infected with Plasmodium vivax) 
from Brazilian Amazon region.
Genotype result nt 125 FYA/FYB 
Donors/Patients
nt 265 FYBWK or FYX GATA (n) FYBES or FY0 or FYB-33 Predicted Phenotype 
Donors/Patients
FYA/FYA G/G 43/51 C/C T/T
FYA/FYX G/A 03/05 C/T T/T Fy(a+b-) n = 108/90
FYA/FYB-33 G/A 62/34 C/C T/C
FYA/FYB G/A 90/109 C/C T/T Fy(a+b+) n = 90/109
FYB/FYB A/A 54/63 C/C T/T
FYB/FYX A/A 06/04 C/T T/T Fy(a-b+) n = 114/109
FYB/FYB-33 A/A 54/42 C/C T/C
FYX/FYX A/A 00/02 T/T T/T Fy(a-b-) n = 18/04
FYB-33/FYB-33 A/A 18/02 C/C C/C
Total 330/312Malaria Journal 2007, 6:167 http://www.malariajournal.com/content/6/1/167
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for the ethnic composition as well as an indicator in the
populational evolution. In the current study, significant
differences in the allelic frequencies of the FY gene were
identified when compared with previous studies of
patients infected with human plasmodium in Brazilian
Amazon regions [17,25-27]. However, the FYA, FYB and
FYB-33 alleles showed differential distributions compared
to the population of the southeastern region of Brazil
[11]. The genotypic compositions obtained in this study
demonstrated significant variations compared to previous
studies performed in the states of Pará and Rio Grande do
Sul [28,29] and in the cities of São Paulo [30], Campinas
[11] and Ribeirão Preto [31] all of which are in the state
of São Paulo, Southeastern region of Brazil.
The currently obtained results showed that the FYA/FYB
genotype was the most common, followed by the
homozygotes for the FYB and FYA alleles and by the het-
erozygotes FYA/FYB-33  and FYB/FYB-33  (Table 1). The
FYB-33/FYB-33 genotype, which is classically seen in indi-
viduals unaffected by P. vivax infection, was identified in
3.2% of the general population and in 5.5% of blood
donors. These numbers differ from previous reports on a
group of malaria patients uninfected by P. vivax in the
state of Rondônia [17], where the frequency of this geno-
type was 12% and also for a mixed sample from the
Northern and Southeastern regions of Brazil [27]. Some
populations had higher genotypic frequencies for FYA/
FYB and FYB/FYB-33 than for a caucasian-like and negroid
population from the Southeastern of Brazil [11]. On the
other hand, the frequency of the FYB-33/FYB-33 genotype
was lower. In fact, with the exception of negroid ethnic
groups, this genotype is extremely rare [12,30,32,33].
The FYA allele is common in European and Oriental peo-
ples but it is rare in African Negroes. Additionally, the FYB
is more common in populations classified as white than
in asiatic and negroid populations [34,35]. The frequency
of the FYA and FYB alleles in the Brazilian Amazon popu-
lation was higher than those in the Southeastern region
[11] probably due to the massive influence of Portuguese
colonization in the North region of Brazil as well as the
presence of Amerindians [36], as recent molecular analy-
sis has corroborated that Amerindians have an Asian ori-
gin [37]. Indeed, in the North region of Brazil, studies
carried out with different tribes of Amerindians have
shown that the FYA allele is the most common [31,38]. As
expected, a lower frequency of the FYB-33  allele was
observed in the North region (P = 0.0001). Although a
high prevalence of this allele was demonstrated in iso-
lated communities in the states of Amapá and Pará, North
region of Brazil [39], the introduction of a negroid ethnic
component in the Amazon region is recent [40,41]. In
respect to the FYX allele, there does not seem to be a differ-
ential ethnic distribution as, the frequency detected here is
similar to those described in other Caucasian-like popula-
tions in Brazil [11] and also in Europe [42].
The different FY allelic frequencies in individuals from
North compared to Southeastern Brazil, may be due to the
contribution of the three major ethnic groups (Europeans,
in particular Portuguese; Blacks and Amerindians) in the
formation of both populations. The Amerindian contri-
Table 2: Comparison of genotyping results and allele frequencies of the Duffy Blood Group System among blood donors and patients 
infected with P. vivax from Brazilian Amazon region.
Duffy blood group system Brazilian Amazon Region
Genotypes Predicted Phenotype Donors (n = 330) Patients P. vivax (n = 312) P
FYA/FYA Fy(a+b-) 43 51 0,2644
FYA/FYX Fy(a+b-) 3 5 0,4942
FYA/FYB-33 Fy(a+b-) 62 34 0,0055*
FYA/FYB Fy(a+b+) 90 109 0,0404*
FYB/FYB Fy(a-b+) 54 63 0,2208
FYB/FYX Fy(a-b+) 6 4 0,7530
FYX/FYX Fy(a-b-) - 2 0,2358
FYB/FYB-33 Fy(a-b+) 54 42 0,3205
FYB-33/FYB-33 Fy(a-b-) 18 2 0,0003*
Alelles Alelles Frequencies
FYA 0,365 0,400 0,2896
FYB 0,390 0,450 0,0351
FYX 0,014 0,021 0,5726
FYB-33 0,230 0,128 0,0000
* Fisher's Exact Test.Malaria Journal 2007, 6:167 http://www.malariajournal.com/content/6/1/167
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bution was higher in the north of the country whereas
European migration took place more in the South and
Southeastern regions [43-45]. In spite of the current
knowledge of the relationship between structure/function
and tissue location of DARC, the functional significance
of each of the alleles and the different genotypic combina-
tions require further elucidation. The variation in the eth-
nic composition of the urban and rural populations of the
Brazilian Amazon region and of distinct regions in Brazil
[26,46], may influence the allelic and genotypic distribu-
tions reflecting in matrixes of genetic mechanisms favora-
ble to the susceptibility to infectious and parasitic
diseases, in particular to malaria.
The frequency of the allele with the FY GATA mutation
(FYB-33) was greater in blood donors than in patients
infected with malaria (P = 0.0033), suggesting that there
is a reduction in the infection rate of carriers of the FYB-33
allele. These results were recently reinforced by data from
of individuals infected by P. falciparum when compared to
those infected by P. vivax in Brazilian Amazon regions
[27]. The FYB-33 allele is a variant of the FYB allele result-
ing from a T → C point mutation in the gene promoter
region (neucleotide-33), which abolishes its expression
[9]. The same occurs in the FYA allele, determining the
FYAnull allele [10]. The presence of the FYB-33 allele results
in a 50% reduction in the Duffy protein expression on the
erythrocyte surface [15,47]. This process demonstrates the
action of the dose-related effect of the gene [15,48], which
may limit the invasion process of red blood cells by the
parasite, although susceptibility to P. vivax may occur in
heterozygotic Duffy-negative individuals [13,14]. Thus
the  FY/FYB-33  genotypic combination, with either
Fy(a+b-) or Fy(b+b-), seems to convey a reduction in the
susceptibility to malaria. In vitro studies [15] support this
hypothesis as RBCs that express these phenotypes have a
significant reduction in cytoadherence of the parasite
when compared to RBCs that express Fy(b+b+). Recently,
in Papua New Guinea, a significant reduction in infection
by P. vivax was observed in Duffy negative individuals het-
erozygotic for the FYAnull allele [49].
In this study a low frequency of the negative Duffy geno-
type (FYB-33/FYB-33) was detected among uninfected
subjects. As has previously been demonstrated, the
absence of the Fy antigen in many ethnic Negro groups
and their descendents, does not seem to exert any delete-
rious effect, however it does bestow a natural resistance
against infection by P. vivax [2,9,14,35,50,51]. These indi-
viduals are homozygotes for the FYB  mutation in the
GATA, that completely abolishes the Fy expression in
erythrocytes but not in cells of other tissues [9]. Recent
reports have provided evidence on the transmission
among Duffy-negative patients in Africa [52] and in Brazil
[53]. These data suggest the possibility that P. vivax is uti-
lizing alternative receptors, apart from Fy, for binding in
the erythrocyte invasion process. Whether FYB carrying
the GATA box mutation is the primordial gene that
encodes the Duffy system antigens or whether the GATA
box mutation has evolved to escape malaria infection per
se is controversial. However, the presence of this allele
(FYB-33) may be a demonstration of the selection advan-
tage by mutation in the population. Thus, in the Brazilian
Amazon, where P. vivax predominates, the frequency of
the FYB-33 allele is higher than expected given the ethnic
population, both in terms of heterozygotes and homozy-
gotes. This might, over time, cause an increase in the
number of Duffy-negative individuals in the population
and, as a consequence, a reduction in the rate of infection
by P. vivax in this region.
In the group of patients infected by P. vivax, different
allelic combinations with FYX were detected, including
five (1.6%)FYA/FYX individuals, four (1.3%) FYB/FYX and
two (0.6%) FYX/FYX (Table 2). The frequency of this allele
among patients and blood donors did not show statistical
differences (P = 0.3873). Studies carried out in blood sam-
ples from European and American Caucasians and Afro-
American individuals, demonstrated that the C265T (FYX)
mutation altered the Duffy protein expression on the RBC
surface differently, depending on the ethnic group, using
at least two mechanisms. One mechanism involves silent
transcription in one of the FYB alleles and the other affects
the translation and/or the stability of the protein [47,54].
These studies showed that heterozygote individuals for
the FYX (FYWK) allele have 50% less of the Duffy protein
on the surface of the membrane of the erythrocyte. On the
other hand, individuals homozygotic for the FYX allele
have about one tenth of the antigen expression in the
erythrocytes [47]. However, the information shown by the
present study suggest that these polymorphisms do not
seem to be associated with susceptibility to malaria.
As illustrated in Table 2, a higher frequency of the FYA/
FYB genotype in patients compared to blood donors (P =
0.0404) was detected. In principle, this seems to indicate
that the condition of heterozygosis, resulting from the
expression of the FYA and FYB genes, favors infection by
P. vivax. In fact, as has already been demonstrated by us,
based on a phenotyping study, Fy(a+b+) individuals may
be more susceptible to infection by this species of Plasmo-
dium [16]. Although no qualitative or quantitative meas-
urements of the Duffy glycoprotein expressions were
made in this study, we saw a larger number of malaria epi-
sodes among patients with the heterozygote genotype
than the homozygote genotype. The basis of this observa-
tion has not been determined yet, but the phenotypic [16]
and genotypic data presented from the same Brazilian
Amazon areas associated with pertinent publications,
point to the possibility that heterozygote individualsMalaria Journal 2007, 6:167 http://www.malariajournal.com/content/6/1/167
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modulate the susceptibility to malaria by P. vivax by
means of quantitative and/or qualitative variations that
affect the Duffy antigen expression on erythrocytes. In the
first aspect, in vitro studies demonstrate differences in the
levels of the expression of FY glycoprotein on the surface
of the reticulocytes of Caucasian-like and Afro-American
individuals with the Fy(a+b+) erythrocytic phenotype
[48]. These authors verified that individuals with FYA and
FYB alleles expressed a lower quantity of DARC than het-
erozygotes. Hence, it is possible that heterozygote individ-
uals have a greater repertory of receptors for the possible
variations that occur in the parasite protein binder to the
human erythrocytes.
The recent demonstration of polymorphisms in the Duffy
binding protein in isolates of P. vivax from the Brazilian
Amazon [55] seems to support the observed results. An
association, between human receptor polymorphisms
and variations in the parasite binders of Plasmodium falci-
parum that modulate susceptibility to malaria, was also
demonstrated [19,56-60]. Hence, apart from the different
levels of the expression, the specific conformation of the
Fya and Fyb antigens may determine differences in the
susceptibility to infection. Nevertheless, one of the possi-
ble consequences of differential susceptibility to vivax
malaria could be modifications in allelic frequencies of
FYA and FYB in populations exposed to P. vivax, the most
prevalent species in the Brazilian Amazon region. If in fact
this process occurs as a consequence of infection, it seems
to be necessary, but not sufficient to eliminate heterozy-
gote individuals, even if they are affected by repetitive epi-
sodes of malaria by P. vivax, as the infection is rarely severe
and occurs in the entire age range with different frequen-
cies for different ages and regions of the Brazilian Amazon
without lethality [61,62].
Based on the significant associations described herein, our
data differ from previous studies [17] carried out in the
western Brazilian Amazon region as well as recent studies
of patients from the Brazilian Amazon as a whole [27]. In
respect to the first studies, these differences may be a result
of the small sample sizes initially evaluated; the control
group of the current study was composed of blood donors
who reported never having experienced malaria against
samples from individuals who had P. falciparum previ-
ously evaluated and the various ethnic groups in the dif-
ferent regions studied today (Eastern and Western
Amazon). In relation to the recent studies, different to the
findings observed in this study Brazilian Amazon popula-
tion, the authors detected a significant association among
infections by P. vivax and the FYB/FYB genotype, also con-
flicting with results of Wooley et al [48] in North Ameri-
can individuals (Caucasians and Afro-Americans). These
divergences probably occurred due to the smaller sample
size involved, and the fact that the control group consisted
patients infected by P. falciparum.
Conclusion
The Brazilian population presents an elevated degree of
miscegenation which is implicated in variations in the
allelic distribution of FY, which was also found in this
study. Future analyses that consider haplotypic frequen-
cies of the alleles and quantification of the DARC expres-
sion in populational groups in endemic and non-endemic
areas, increasing the knowledge on the dynamics of this
gene and its possible contribution as a modulator in the
susceptibility to malaria. The data obtained in the present
study supports the hypothesis that individuals with the
FYA/FYB genotype have higher susceptibility to malaria.
The presence of the FYB-33allele may be a selective advan-
tage in the population, reducing the rate of infection by P.
vivax in this region. However, the populational and longi-
tudinal studies must be amplified accompanying groups
of individuals with the FYB-33  allele and the FYA/FYB
genotype, including clinical parameters, as well as the
evaluation of their expressions which may contribute to
better elucidate the physiopathologic differences in this
parasite/host relationship in regions endemic for P. vivax
malaria, in particular the Brazilian Amazon.
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